Carter R A, Hawkins J B, Robinson B H
Br Med J. 1969 Jul 26;3(5664):206-10. doi: 10.1136/bmj.3.5664.206.
Serial studies of iron transport in patients on maintenance dialysis showed normal or raised values in almost all subjects and a transient increase soon after the start of dialysis in three. These patients, who were seldom or never transfused, had low serum iron levels and normal iron-binding capacity with low saturation. Iron transport was substantially increased by parenteral iron-dextran treatment. Tracer studies showed good iron utilization, with transport to the marrow rather than to the liver. In these circumstances iron therapy is safe and beneficial, and a useful rise in red cell mass was shown to result from it. The packed cell volume was found to be a valid index of red cell mass in these patients. Red cell loss in the dialysers was insufficient to account for the observed reduction in red cell survival.
对维持性透析患者铁转运的系列研究表明,几乎所有受试者的铁转运值均正常或升高,3例患者在透析开始后不久出现短暂升高。这些很少或从未接受过输血的患者血清铁水平较低,铁结合能力正常但饱和度较低。胃肠外给予右旋糖酐铁治疗可使铁转运显著增加。示踪研究显示铁利用良好,铁转运至骨髓而非肝脏。在这些情况下,铁治疗是安全且有益的,并且已证明由此可使红细胞量有效增加。发现血细胞比容是这些患者红细胞量的有效指标。透析器中的红细胞丢失不足以解释观察到的红细胞存活期缩短。